29.04.2014The 18th MedTech Investing Europe ConferenceYou are hereEventsBioAlps eventsThe 18th MedTech Investing Europe Conference
Chaired by Benoit Dubuis, President of BioAlps and one of the sector’s leading lights in Europe, this event will allow you to:
Invest in the best opportunities available in MedTech... More than 40 MedTech companies showcasing their latest innovations and investment opportunities in a wide range of sectors.
Hear from the most influential experts about the key issues facing this sector today... Our panels of international experts from leading MedTech corporations will be speaking alongside some of the most experienced entrepreneurs and venture capitalists. Learn how best to drive your strategy and development.
Unite with the international MedTech investment community... Last year the event attracted over 140 delegates from 16 countries including:
- Family Offices
- Venture Capital
- Private Equity
- Corporate VC
- Private Wealth Holders
- Angel Investors
BioTaiwan 201819.07.2018BioTaiwan Exhibition 2018 will be held from 19 to 22 July at the TWTC Nangang Exhibition Hall in Taipei, Taiwan.
DFB Pharmaceuticals Inc.Supplier & Engineering, Consumables & ReagentsSummary of activity
DFB BioScience's primary focus is in the field of Cell Biology and Cell based therapies. The company develops Cell based therapies for treating chronic and acute wounds. Our R&D program includes several products at different development stage (preclinical, clinical, market approval). DFB BioScience can also provide manufacturing services for cell banking and Cell based products clinical manufacturing.
DFB BioScience is one of DFB Pharmaceuticals’ International branches. DFB Pharmaceuticals Inc., the mother company, is a fully integrated pharmaceutical group composed of two main divisions, DPT Laboratories, a Contract Manufacturing Organization providing customers with drug development and manufacturing services, and Healthpoint, which develops & markets pharmaceutical and medical products for chronic wounds.